|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4353 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4353 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/5375 | (2013.01) | ||
| A61K 31/5375 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3568204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18701574.8 |
| Date of filing the European patent application | 2018-01-08 | |
| (97) | Date of publication of the European application | 2019-11-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/050111 |
| Date | 2018-01-08 |
| (87) | Number | WO 2018/130928 |
| Date | 2018-07-19 |
| (30) | Number | Date | Country code |
| 201762444493 P | 2017-01-10 | US |
| (72) |
DARDAEI ALGHALANDIS, Leila , US
ENGELMAN, Jeffrey Adam , US
HAO, Huaixiang , US
LI, Fang , US
LAMARCHE, Matthew J. , US
WANG, Hui-Qin , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITAL , 55 Fruit Street, Boston, MA 02114, US |
| (54) | PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITOR |
| PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITOR |